Cargando…
1433. Factors Associated with Unsuccessful Treatment Outcomes among Patients with Rifampicin Resistant Tuberculosis - Tajikistan, 2015-2020
BACKGROUND: Tajikistan has a high burden of multidrug resistant TB, including rifampicin-resistant TB (RR-TB). Treatment options are more limited and include standard treatment (T1), bedaquiline/delamanid contained individual treatment (T2), short treatment (T3), modified short treatment (T4), and b...
Autores principales: | Tilloeva, Zulfiya Haybullo, Sijotkhonov, Amidkhan S, Zikriyarova, Sanam, Pirmahmadzoda, Bobochon, Alaverdyan, Sevak, Nabirova, Dilyara, Horth, Roberta, Dzhafarov, Navruz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753006/ http://dx.doi.org/10.1093/ofid/ofac492.1262 |
Ejemplares similares
-
1894. Delay in TB care before and during the COVID-19 pandemic, Dushanbe, Tajikistan, 2022
por: Sharifov, Rajabali, et al.
Publicado: (2023) -
2321. Prevalence and determinants of depression among healthcare workers during the COVID-19 pandemic in Khujand, Tajikistan, 2022
por: Silemonshoeva, Jamila, et al.
Publicado: (2023) -
Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–2018
por: Sayfutdinov, Zayniddin, et al.
Publicado: (2021) -
445. High HCV Treatment Success among People Living with HIV - Kyrgyzstan, 2018-2021
por: Kyzy, Nasyat Kemelbek, et al.
Publicado: (2022) -
Therapies for people hospitalized with COVID-19 and alignment with national clinical guidelines in a large hospital, Almaty, Kazakhstan, 2020–2021
por: Gazezova, Saya, et al.
Publicado: (2023)